The Changing Drug Culture: Use and Misuse of Appearance- and Performance-Enhancing Drugs

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Awareness of the prevalence of the use of appearance- and performance-enhancing drugs (APEDs) is increasing. Users range from professional athletes and bodybuilders to amateurs and adolescents. Anabolic androgenic steroids (AASs) are the most widely used APEDs, typically for purposes of building muscle mass, in forms that include pills, injections, topical preparations, and transdermal systems. AASs are often used in combination with augmenting drugs taken to enhance androgen production and, for men, to decrease estrogen production. These include aromatase inhibitors, clomiphene, selective estrogen receptor modulators, and human chorionic gonadotropin. Other drugs used with the intention of improving athletic performance include human growth hormone, insulinlike growth factor 1, insulin, erythropoietin, stimulants, diuretics, levothyroxine, and gamma-hydroxybutyrate. Use of APEDs is increasing, with up to 5% of male and 2% of female college athletes using AASs and reports of a more than 20% usage rate among teenagers. Although many of these substances can increase muscle mass when combined with high levels of exercise and specific diets, it is not clear that they improve athletic performance. Furthermore, they are associated with a variety of serious adverse effects. AASs, in particular, can cause hepatotoxicity and acute cardiac events. Behavioral and psychiatric symptoms also can occur.

Original languageEnglish (US)
Pages (from-to)30-43
Number of pages14
JournalFP essentials
Volume441
StatePublished - Feb 1 2016

Fingerprint

Performance-Enhancing Substances
Testosterone Congeners
Athletic Performance
Athletes
Pharmaceutical Preparations
Sodium Oxybate
Selective Estrogen Receptor Modulators
Muscles
Behavioral Symptoms
Clomiphene
Aromatase Inhibitors
Human Growth Hormone
Chorionic Gonadotropin
Erythropoietin
Thyroxine
Diuretics
Androgens
Psychiatry
Intercellular Signaling Peptides and Proteins
Estrogens

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The Changing Drug Culture : Use and Misuse of Appearance- and Performance-Enhancing Drugs. / Albertson, Timothy E; Chenoweth, James; Colby, Daniel; Sutter, Mark E.

In: FP essentials, Vol. 441, 01.02.2016, p. 30-43.

Research output: Contribution to journalReview article

@article{a72feb1105534c5c9963cd22013025b6,
title = "The Changing Drug Culture: Use and Misuse of Appearance- and Performance-Enhancing Drugs",
abstract = "Awareness of the prevalence of the use of appearance- and performance-enhancing drugs (APEDs) is increasing. Users range from professional athletes and bodybuilders to amateurs and adolescents. Anabolic androgenic steroids (AASs) are the most widely used APEDs, typically for purposes of building muscle mass, in forms that include pills, injections, topical preparations, and transdermal systems. AASs are often used in combination with augmenting drugs taken to enhance androgen production and, for men, to decrease estrogen production. These include aromatase inhibitors, clomiphene, selective estrogen receptor modulators, and human chorionic gonadotropin. Other drugs used with the intention of improving athletic performance include human growth hormone, insulinlike growth factor 1, insulin, erythropoietin, stimulants, diuretics, levothyroxine, and gamma-hydroxybutyrate. Use of APEDs is increasing, with up to 5{\%} of male and 2{\%} of female college athletes using AASs and reports of a more than 20{\%} usage rate among teenagers. Although many of these substances can increase muscle mass when combined with high levels of exercise and specific diets, it is not clear that they improve athletic performance. Furthermore, they are associated with a variety of serious adverse effects. AASs, in particular, can cause hepatotoxicity and acute cardiac events. Behavioral and psychiatric symptoms also can occur.",
author = "Albertson, {Timothy E} and James Chenoweth and Daniel Colby and Sutter, {Mark E}",
year = "2016",
month = "2",
day = "1",
language = "English (US)",
volume = "441",
pages = "30--43",
journal = "FP essentials",
issn = "2159-3000",
publisher = "American Academy of Family Physicians",

}

TY - JOUR

T1 - The Changing Drug Culture

T2 - Use and Misuse of Appearance- and Performance-Enhancing Drugs

AU - Albertson, Timothy E

AU - Chenoweth, James

AU - Colby, Daniel

AU - Sutter, Mark E

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Awareness of the prevalence of the use of appearance- and performance-enhancing drugs (APEDs) is increasing. Users range from professional athletes and bodybuilders to amateurs and adolescents. Anabolic androgenic steroids (AASs) are the most widely used APEDs, typically for purposes of building muscle mass, in forms that include pills, injections, topical preparations, and transdermal systems. AASs are often used in combination with augmenting drugs taken to enhance androgen production and, for men, to decrease estrogen production. These include aromatase inhibitors, clomiphene, selective estrogen receptor modulators, and human chorionic gonadotropin. Other drugs used with the intention of improving athletic performance include human growth hormone, insulinlike growth factor 1, insulin, erythropoietin, stimulants, diuretics, levothyroxine, and gamma-hydroxybutyrate. Use of APEDs is increasing, with up to 5% of male and 2% of female college athletes using AASs and reports of a more than 20% usage rate among teenagers. Although many of these substances can increase muscle mass when combined with high levels of exercise and specific diets, it is not clear that they improve athletic performance. Furthermore, they are associated with a variety of serious adverse effects. AASs, in particular, can cause hepatotoxicity and acute cardiac events. Behavioral and psychiatric symptoms also can occur.

AB - Awareness of the prevalence of the use of appearance- and performance-enhancing drugs (APEDs) is increasing. Users range from professional athletes and bodybuilders to amateurs and adolescents. Anabolic androgenic steroids (AASs) are the most widely used APEDs, typically for purposes of building muscle mass, in forms that include pills, injections, topical preparations, and transdermal systems. AASs are often used in combination with augmenting drugs taken to enhance androgen production and, for men, to decrease estrogen production. These include aromatase inhibitors, clomiphene, selective estrogen receptor modulators, and human chorionic gonadotropin. Other drugs used with the intention of improving athletic performance include human growth hormone, insulinlike growth factor 1, insulin, erythropoietin, stimulants, diuretics, levothyroxine, and gamma-hydroxybutyrate. Use of APEDs is increasing, with up to 5% of male and 2% of female college athletes using AASs and reports of a more than 20% usage rate among teenagers. Although many of these substances can increase muscle mass when combined with high levels of exercise and specific diets, it is not clear that they improve athletic performance. Furthermore, they are associated with a variety of serious adverse effects. AASs, in particular, can cause hepatotoxicity and acute cardiac events. Behavioral and psychiatric symptoms also can occur.

UR - http://www.scopus.com/inward/record.url?scp=84975298253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975298253&partnerID=8YFLogxK

M3 - Review article

C2 - 26881771

AN - SCOPUS:84975298253

VL - 441

SP - 30

EP - 43

JO - FP essentials

JF - FP essentials

SN - 2159-3000

ER -